Emma Morris
Senior Postdoctoral Researcher
I obtained a first class honors degree from the The Open University in 2008. Following that I joined the Nuffield Department of Surgery at Oxford where I graduated with a DPhil in 2013. My thesis focused on investigating the role of co-regulators of p53 in prostate development and prostate cancer progression. My current research in Claire Edwards’s lab focuses on the fatal hematologic malignancy multiple myeloma.
I am currently investigating the tumour-suppressive effects of adiponectin, an adipokine which has previously been shown to kill myeloma cells. I am also interested in the pro-survival mechanisms of myeloma cells, in particular the process of autophagy. Many patients experience resistance to conventional singular therapies, and so using combination therapies to target pathways such as adiponectin signalling and the autophagy pathway could enhance myeloma cell death and therefore patient outcome.
Recent publications
-
Journal article
Morris EV. and Edwards CM., (2021), Best pract res clin endocrinol metab, 35
-
Journal article
Morris EV. et al, (2020), J bone miner res, 35, 942 - 955
-
Journal article
Gooding S. et al, (2019), Nat commun, 10
-
Journal article
Morris EV. and Edwards CM., (2019), Bone, 118, 42 - 46
-
Journal article
Morris EV. and Edwards CM., (2018), J cell physiol, 233, 9159 - 9166
-
Journal article
Morris EV. and Edwards CM., (2016), J bone oncol, 5, 121 - 123
-
Journal article
Verrill C. et al, (2016), Oncotarget, 7, 1107 - 1119
-
Journal article
Morris EV. and Edwards CM., (2016), Front endocrinol (lausanne), 7
-
Journal article
Morris EV. et al, (2014), Cell death dis, 5